Serum Prolactin Levels in Dermatological Diseases: A Case-Control Study

    April 2015 in “ Journal of Dermatology and Dermatologic Surgery ”
    Nadia Abdalhafid Elsherif, Abdalla I. El‐Sherif, Salwa A. El-Dibany
    New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study found higher serum prolactin levels in patients with psoriasis, vitiligo, and alopecia areata compared to controls, and prolactin levels correlated with disease severity in psoriasis and alopecia areata but not vitiligo.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    In a case-control study with 100 subjects, researchers found that serum prolactin (PRL) levels were significantly higher in 75 patients with psoriasis, vitiligo, and alopecia areata compared to 25 healthy controls. The mean serum PRL levels were 21.8 ± 11.5 ng/ml in alopecia areata patients, 16.9 ± 6.8 ng/ml in those with psoriasis, and 16.6 ± 8.0 ng/ml in vitiligo patients. There was also a significant correlation between serum PRL levels and disease severity in alopecia areata and psoriasis patients, but not in those with vitiligo. The study suggested that prolactin might contribute to the pathogenesis of these dermatological diseases and could be a marker for disease activity in psoriasis and alopecia areata.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results